Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748317 · ClinicalTrials.gov registry record · Phase 2
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
A Phase 2 study of Lower Urinary Tract Symptoms, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
- 2
- Study locations
NCT02748317: Completed Phase 2 study of Lower Urinary Tract Symptoms, sponsored by Medstar Health Research Institute.
NCT02748317 is a Phase 2 study of Lower Urinary Tract Symptoms that has completed, run by Medstar Health Research Institute. The registered enrollment target is 96 participants, below the 746-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02748317, a Phase 2 study of Lower Urinary Tract Symptoms, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
- 2
- Study locations
Study Summary
As a collaborative effort between MedStar National Rehabilitation Hospital (NRH)/MedStar Health Research Institute (MHRI), Children's National Medical Center (CNMC) Department of Urology, Children's Research Institute (CRI) Center for Genetic Medicine Research, and Georgetown University Medical Center, the overall objective of this study is to develop, validate, and assess a patient-initiated, probiotics-based, self management protocol that is initiated at the time of urinary symptoms. The self-management protocol will allow patients to manage urinary symptoms and avoid potentially unnecessary antibiotic use, and provide a readily-available means of maintaining health, function, and independence throughout the lifespan.
Primary Outcome
Total Adverse Events (AE + Serious AE) per participant .
Conditions Studied
Interventions
- DRUG Lactobacillus rhamnosus GG
Study Locations (2)
District of Columbia
- Children's National Medical Center - Washington D.C.
- MedStar National Rehabilitation Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-10-31 |
| Phase | Phase 2 |
What the finished NCT02748317 record still lists
NCT02748317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 746-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Lactobacillus rhamnosus GG is the first listed.
NCT02748317 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02748317 about?
NCT02748317 is a clinical study titled "Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB". As a collaborative effort between MedStar National Rehabilitation Hospital (NRH)/MedStar Health Research Institute (MHRI), Children's National Medical Center (CNMC) Department of Urology, Children's Research Institute (CRI) Center for Genetic Medicine Research, and Georgetown University Medical Cent...
What is the current status of trial NCT02748317?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2016-01. Estimated completion is 2018-10-31.
What conditions does trial NCT02748317 study?
This clinical trial studies the following conditions: Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT02748317?
The interventions under investigation include: Lactobacillus rhamnosus GG (DRUG).
Who is sponsoring clinical trial NCT02748317?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02748317 being conducted?
This trial has 2 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02748317's enrollment target sits among peer trials
96 11th of 21 higher than 11 of 21 other Lower Urinary Tract Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lower Urinary Tract Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
RECRUITING · Phase 2
-
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
COMPLETED · Phase 2
-
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
COMPLETED · Phase 2
-
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
COMPLETED · Phase 2
-
US Imaging for the Assessment of LUTS
RECRUITING
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia